Immunome (NASDAQ:IMNM) Now Covered by Lake Street Capital
Equities researchers at Lake Street Capital started coverage on shares of Immunome (NASDAQ:IMNM – Get Free Report) in a report issued on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Lake Street Capital’s price target would indicate a potential upside of 268.59% from the company’s previous […]
Equities researchers at Lake Street Capital started coverage on shares of Immunome (NASDAQ:IMNM – Get Free Report) in a report issued on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Lake Street Capital’s price target would indicate a potential upside of 268.59% from the company’s previous […]
